Cerecor Inc (NASDAQ:CERC) major shareholder Armistice Capital Master Fund purchased 10,000 shares of Cerecor stock in a transaction that occurred on Friday, June 7th. The shares were bought at an average price of $4.88 per share, for a total transaction of $48,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Armistice Capital Master Fund also recently made the following trade(s):

  • On Wednesday, June 5th, Armistice Capital Master Fund purchased 15,000 shares of Cerecor stock. The shares were bought at an average price of $4.81 per share, for a total transaction of $72,150.00.
  • On Friday, May 31st, Armistice Capital Master Fund purchased 51,000 shares of Cerecor stock. The shares were bought at an average price of $4.71 per share, for a total transaction of $240,210.00.
  • On Tuesday, May 28th, Armistice Capital Master Fund purchased 29,000 shares of Cerecor stock. The shares were bought at an average price of $5.02 per share, for a total transaction of $145,580.00.
  • On Friday, May 17th, Armistice Capital Master Fund purchased 10,000 shares of Cerecor stock. The shares were bought at an average price of $5.18 per share, for a total transaction of $51,800.00.
  • On Tuesday, May 14th, Armistice Capital Master Fund purchased 20,000 shares of Cerecor stock. The shares were bought at an average price of $4.97 per share, for a total transaction of $99,400.00.
  • On Wednesday, March 27th, Armistice Capital Master Fund purchased 50,000 shares of Cerecor stock. The shares were bought at an average price of $5.47 per share, for a total transaction of $273,500.00.

Shares of CERC stock traded up $0.04 during trading hours on Wednesday, reaching $5.29. The company’s stock had a trading volume of 1,157 shares, compared to its average volume of 80,720. Cerecor Inc has a one year low of $2.71 and a one year high of $7.65. The company has a current ratio of 0.95, a quick ratio of 0.91 and a debt-to-equity ratio of 0.62.

Cerecor (NASDAQ:CERC) last issued its quarterly earnings data on Thursday, May 9th. The company reported ($0.13) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.16) by $0.03. The firm had revenue of $5.41 million for the quarter, compared to analyst estimates of $4.85 million. Cerecor had a negative return on equity of 120.67% and a negative net margin of 226.50%. On average, equities research analysts expect that Cerecor Inc will post -0.64 earnings per share for the current fiscal year.

Several hedge funds have recently modified their holdings of the company. Opaleye Management Inc. boosted its position in shares of Cerecor by 5.2% during the first quarter. Opaleye Management Inc. now owns 2,300,000 shares of the company’s stock valued at $13,432,000 after purchasing an additional 114,464 shares in the last quarter. Prosight Management LP purchased a new position in Cerecor in the fourth quarter valued at about $994,000. Geode Capital Management LLC grew its position in shares of Cerecor by 50.7% in the fourth quarter. Geode Capital Management LLC now owns 94,990 shares of the company’s stock valued at $306,000 after purchasing an additional 31,951 shares during the last quarter. Vanguard Group Inc grew its position in shares of Cerecor by 10.1% in the third quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock valued at $411,000 after purchasing an additional 8,094 shares during the last quarter. Finally, Spark Investment Management LLC increased its position in shares of Cerecor by 60.5% in the first quarter. Spark Investment Management LLC now owns 83,000 shares of the company’s stock worth $484,000 after acquiring an additional 31,290 shares in the last quarter. Hedge funds and other institutional investors own 53.94% of the company’s stock.

A number of equities research analysts have recently weighed in on the company. TheStreet lowered Cerecor from a “c-” rating to a “d+” rating in a research report on Wednesday, May 29th. HC Wainwright set a $11.00 price objective on Cerecor and gave the stock a “buy” rating in a research report on Wednesday, April 17th. LADENBURG THALM/SH SH reiterated a “buy” rating and issued a $8.00 price objective on shares of Cerecor in a research report on Monday, May 13th. ValuEngine lowered Cerecor from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, May 1st. Finally, Maxim Group reiterated a “buy” rating and issued a $10.00 price objective on shares of Cerecor in a research report on Friday, May 10th. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $9.67.

ILLEGAL ACTIVITY WARNING: “Cerecor Inc (NASDAQ:CERC) Major Shareholder Purchases $48,800.00 in Stock” was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://theolympiareport.com/2019/06/12/cerecor-inc-nasdaqcerc-major-shareholder-purchases-48800-00-in-stock.html.

About Cerecor

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device.

See Also: What is a Fibonacci Channel?

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.